Ubiquitin ligase defect by <i>DCAF8</i> mutation causes HMSN2 with giant axons
Christopher J. Klein(Mayo Clinic), P. James B. Dyck(Mayo Clinic), Elizabeth J. Atkinson(Mayo Clinic in Arizona), Georges Mer(Mayo Clinic), Sumit Middha(Memorial Sloan Kettering Cancer Center), Kristen Zukosky(National Institutes of Health), Hans H. Goebel(University Medical Center of the Johannes Gutenberg University Mainz), Yanhong Wu(Shandong University of Technology), Xiaohui Duan(Peking University), Peter Vogel(Lexicon Pharmaceuticals (United States)), C. Bönnemann(National Institutes of Health), Maria Victoria Botuyan(Mayo Clinic)
Cited by 32
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
New loci associated with kidney function and chronic kidney disease
|Nature Genetics|2010|809
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
|Annals of Neurology|2018|758